piracetam has been researched along with Xanthomatosis, Cerebrotendinous in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Xanthomatosis, Cerebrotendinous: An autosomal recessive lipid storage disorder due to mutation of the gene CYP27A1 encoding a CHOLESTANETRIOL 26-MONOOXYGENASE. It is characterized by large deposits of CHOLESTEROL and CHOLESTANOL in various tissues resulting in xanthomatous swelling of tendons, early CATARACT, and progressive neurological symptoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uygunoglu, U | 1 |
| Gunduz, A | 1 |
| Menku, SF | 1 |
| Yilmaz, B | 1 |
| Hatipoglu, E | 1 |
| Yalcinkaya, C | 1 |
| Saip, S | 1 |
| Apaydin, H | 1 |
1 other study available for piracetam and Xanthomatosis, Cerebrotendinous
| Article | Year |
|---|---|
Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.
Topics: Adult; Ankle; Anti-Dyskinesia Agents; Brain; Cerebellar Ataxia; Cervical Vertebrae; Female; Humans; | 2014 |